SRx Health Solutions Shareholders Unanimously Approve Acquisition by Better Choice Company
Better Choice Company (NYSE American: BTTR) announced that shareholders of SRx Health Solutions have overwhelmingly approved the proposed acquisition, with approximately 93% voting in favor. Better Choice will hold its Special Meeting on March 21, 2025, at 9:00 a.m. ET via live webcast for its stockholders to vote on the acquisition.
The record date for stockholder voting eligibility remains January 21, 2025, and stockholders as of this date can vote even if they have since sold their shares. Previously submitted proxies will be valid for all proposals unless properly revoked. The company plans to file and distribute a supplementary Proxy Statement with the SEC to ensure stockholders have adequate time to review updated materials and make informed voting decisions.
Better Choice Company (NYSE American: BTTR) ha annunciato che gli azionisti di SRx Health Solutions hanno approvato in modo schiacciante l'acquisizione proposta, con circa il 93% che ha votato a favore. Better Choice terrà la sua Riunione Straordinaria il 21 marzo 2025, alle 9:00 ET tramite webcast dal vivo, per consentire ai suoi azionisti di votare sull'acquisizione.
La data di registrazione per l'idoneità al voto degli azionisti rimane il 21 gennaio 2025, e gli azionisti in questa data possono votare anche se hanno successivamente venduto le loro azioni. I proxy precedentemente inviati saranno validi per tutte le proposte, a meno che non siano revocati correttamente. L'azienda prevede di presentare e distribuire un Supplemento al Documento di Voto alla SEC per garantire che gli azionisti abbiano tempo adeguato per esaminare i materiali aggiornati e prendere decisioni di voto informate.
Better Choice Company (NYSE American: BTTR) anunció que los accionistas de SRx Health Solutions han aprobado abrumadoramente la adquisición propuesta, con aproximadamente el 93% votando a favor. Better Choice llevará a cabo su Reunión Especial el 21 de marzo de 2025, a las 9:00 a.m. ET a través de una transmisión en vivo para que sus accionistas voten sobre la adquisición.
La fecha de registro para la elegibilidad de voto de los accionistas sigue siendo el 21 de enero de 2025, y los accionistas en esta fecha pueden votar incluso si han vendido sus acciones desde entonces. Los poderes ya presentados serán válidos para todas las propuestas, a menos que sean revocados adecuadamente. La empresa planea presentar y distribuir un Documento de Poder Suplementario a la SEC para asegurar que los accionistas tengan tiempo suficiente para revisar los materiales actualizados y tomar decisiones de voto informadas.
Better Choice Company (NYSE American: BTTR)는 SRx Health Solutions의 주주들이 제안된 인수를 압도적으로 승인했으며, 약 93%가 찬성 투표를 했다고 발표했습니다. Better Choice는 2025년 3월 21일 오전 9시(ET)에 주주들이 인수에 대해 투표할 수 있도록 생중계되는 특별 회의를 개최할 예정입니다.
주주 투표 자격의 기준일은 2025년 1월 21일로 유지되며, 이 날짜 기준으로 주주들은 주식을 판매했더라도 투표할 수 있습니다. 이전에 제출된 위임장은 적절하게 철회되지 않는 한 모든 제안에 대해 유효합니다. 이 회사는 주주들이 업데이트된 자료를 검토하고 정보에 기반한 투표 결정을 내릴 수 있도록 SEC에 보충 위임장서를 제출하고 배포할 계획입니다.
Better Choice Company (NYSE American: BTTR) a annoncé que les actionnaires de SRx Health Solutions ont approuvé à une large majorité l'acquisition proposée, avec environ 93 % des votes en faveur. Better Choice tiendra sa Réunion Spéciale le 21 mars 2025 à 9h00 ET via un webinaire en direct pour permettre à ses actionnaires de voter sur l'acquisition.
La date d'enregistrement pour l'éligibilité au vote des actionnaires reste le 21 janvier 2025, et les actionnaires à cette date peuvent voter même s'ils ont vendu leurs actions depuis. Les procurations précédemment soumises seront valables pour toutes les propositions, sauf si elles sont dûment révoquées. L'entreprise prévoit de déposer et de distribuer un Document de Procuration Supplémentaire auprès de la SEC pour s'assurer que les actionnaires disposent d'un temps adéquat pour examiner les documents mis à jour et prendre des décisions de vote éclairées.
Better Choice Company (NYSE American: BTTR) hat bekannt gegeben, dass die Aktionäre von SRx Health Solutions den vorgeschlagenen Erwerb überwältigend genehmigt haben, wobei etwa 93 % für die Zustimmung gestimmt haben. Better Choice wird am 21. März 2025 um 9:00 Uhr ET eine außerordentliche Hauptversammlung per Live-Stream abhalten, damit die Aktionäre über den Erwerb abstimmen können.
Das Stichtagsdatum für die Wahlberechtigung der Aktionäre bleibt der 21. Januar 2025, und Aktionäre zu diesem Datum können auch abstimmen, wenn sie ihre Aktien seitdem verkauft haben. Zuvor eingereichte Vollmachten sind für alle Vorschläge gültig, es sei denn, sie werden ordnungsgemäß widerrufen. Das Unternehmen plant, eine ergänzende Vollmachtsmitteilung bei der SEC einzureichen und zu verteilen, um sicherzustellen, dass die Aktionäre ausreichend Zeit haben, um die aktualisierten Materialien zu überprüfen und informierte Abstimmungsentscheidungen zu treffen.
- 93% of SRx Health Solutions shareholders approved the acquisition
- Significant shareholder support indicates strong confidence in the merger
- None.
Insights
The overwhelming shareholder approval from SRx Health Solutions, with
The upcoming Better Choice special meeting on March 21 represents the final key milestone in the acquisition process. The company's decision to file a supplementary proxy statement indicates a thorough approach to shareholder communication and compliance, which helps minimize legal risks and potential shareholder disputes that could delay closing.
This acquisition marks a strategic expansion in the growing pet health and wellness sector, which has seen increasing consolidation activity. The pet health market has demonstrated resilience during economic downturns, with consistent growth driven by increasing pet ownership and higher spending on pet healthcare. For Better Choice, this acquisition could provide several strategic advantages:
- Enhanced product portfolio and market reach in the pet health segment
- Potential operational synergies and cost efficiencies
- Strengthened competitive position against larger industry players
- Access to SRx's existing customer base and distribution channels
The high shareholder approval rate suggests strong confidence in the deal's valuation and strategic rationale, typically indicating a well-structured transaction that appropriately balances the interests of both companies' shareholders.
TAMPA, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that SRx Health Solutions, Inc. (“SRx”) held its special meeting of shareholders whereby approximately
Better Choice will host its Special Meeting at 9:00 a.m., Eastern Time, on March 21, 2025, exclusively via live webcast at the following address: https://east.virtualshareholdermeeting.com/vsm/web?pvskey=BTTR2025SM. The record date for the stockholders to vote at the Special Meeting remains the close of business on January 21, 2025 (the “Record Date”). Stockholders as of the Record Date can vote, even if they have subsequently sold their shares. Proxies previously submitted with respect to the Special Meeting will be voted on all proposals at the adjourned Special Meeting unless properly revoked in accordance with the procedures described in the Proxy Statement, and stockholders who have previously submitted a proxy or otherwise voted need not take any action.
The Company intends to file with the SEC and mail a supplement to the Proxy Statement in connection with the Special Meeting to provide Better Choice stockholders sufficient time to review the updated materials and cast their votes on a fully informed basis.
About Better Choice Company Inc.
Better Choice Company Inc. is a rapidly growing pet health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier, and longer lives. We take an alternative, nutrition-based approach to pet health relative to conventional dog and cat food offerings and position our portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. We have a demonstrated, multi-decade track record of success selling trusted pet health and wellness products and leverage our established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. We sell the majority of our dog food, cat food and treats under the Halo brand, which is focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats. For more information, please visit https://www.betterchoicecompany.com.
About SRX Health
SRx operates as a Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry. Distinguishing itself as a National Specialty Pharmacy provider, SRx concentrates on overseeing a patient's healthcare journey, spanning from acute pharmaceutical needs to chronic and rare disease management. This unique focus positions SRx to deliver a more holistic and integrated solution, catering to the requirements of both patients and key healthcare stakeholders. Our all-encompassing end-to-end offerings include wholesale/distribution facilities, patient support programs, infusion clinics, retail pharmacies, co-designed clinical programs, clinical trials, and diagnostic services.
Our strategic growth plan is forward-thinking and revolves around fostering increased collaboration with pharmaceutical manufacturers and prescribers. With a specific emphasis on the expanding market of chronic and rare diseases, we target specialty drugs associated with closed and limited distribution networks. The objective is to broaden their distribution and improve accessibility. Our overarching goal is to elevate our current presence from 34 to 100 specialty pharmacy locations across mid-sized population centers throughout Canada, thereby enhancing the scope of healthcare services and establishing new industry benchmarks. In the subsequent phase of SRx's evolution, we aim to extend our reach beyond the borders of Canada. Leveraging our comprehensive approach, we aspire to simplify healthcare on a global scale. For more information on SRx, please visit https://www.srxhealth.ca.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Company Contact:
Better Choice Company, Inc.
Kent Cunningham, CEO
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com
FAQ
What percentage of SRx Health Solutions shareholders approved the Better Choice (BTTR) acquisition?
When is Better Choice Company (BTTR) holding its Special Meeting for the SRx acquisition?
What is the record date for Better Choice (BTTR) shareholders to vote on the SRx acquisition?
Can Better Choice (BTTR) shareholders who sold their shares after January 21, 2025 still vote?
